Budget Impact of Dabrafenib and Trametinib in Combination as Adjuvant Treatment of BRAF V600E/K Mutation-Positive Melanoma from a U.S. Commercial Payer Perspective
| Image |  |
|---|---|
| Description | scientific article published on 01 November 2019 |
| Author/s |
author: Margaret Gerbasi |
| Publication date | November 1, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |